Andrew Aldridge, Partner & Head of Marketing at Deepbridge, recently spoke with Professional Adviser to discuss the UK Government's current tagline of 'Building Back Better' which is focused on the realisation that we all can live in a smarter way and that the UK has the opportunity to be at the forefront of twenty-first century sus
GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently won a £50,000 award that is to be given to Shannon Beattie (CEO - GenoME Diagnostics) as part of the celebrations marking International Women’s Day on March 8th 2022, which will be used to aid early detection of ovarian cancer.
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Money Marketing to share his thoughts regarding how the Enterprise Investment Scheme (EIS) can help reduce client income tax bills.
As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund.
Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Professional Adviser to share his thoughts regarding the world of tax-efficient investments and assesses which relief is the trump card for advisers and clients.
Deepbridge Capital has deployed over £50 million of capital into UK life sciences companies.
The Deepbridge Life Sciences EIS was launched in 2017 as our first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare sectors.
